Blueshift Asset Management, LLC Iovance Biotherapeutics, Inc. Transaction History

Blueshift Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$7.78 - $14.19 $123,165 - $224,641	15,831 New	15,831 $126,000
Q1 2020 May 14, 2020	SELL	$19.54 - $38.85 $217,851 - $433,138	-11,149 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $200,124 - $327,892	11,149 New	11,149 $309,000
Q1 2019 May 14, 2019	SELL	$8.41 - $11.26 $204,573 - $273,899	-24,325 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$7.51 - $11.93 $182,680 - $290,197	24,325 New	24,325 $215,000

320

239M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $958M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.